As of 2026-03-20, the Relative Valuation of Vaxart Inc (VXRT) is (2.03) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.32 USD, the upside of Vaxart Inc based on Relative Valuation is -733.4%.
The range of the Relative Valuation is (1.81) - (2.10) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 18.6x - 22.9x | 20.6x |
| Forward P/E multiples | 17.8x - 21.6x | 21.0x |
| Fair Price | (1.81) - (2.10) | (2.03) |
| Upside | -667.0% - -757.8% | -733.4% |
| Date | P/E |
| 2026-03-17 | -6.93 |
| 2026-03-16 | -6.97 |
| 2026-03-13 | -6.48 |
| 2026-03-12 | -7.56 |
| 2026-03-11 | -7.88 |
| 2026-03-10 | -7.90 |
| 2026-03-09 | -8.21 |
| 2026-03-06 | -7.58 |
| 2026-03-05 | -7.40 |
| 2026-03-04 | -7.80 |
| 2026-03-03 | -7.70 |
| 2026-03-02 | -7.98 |
| 2026-02-27 | -8.16 |
| 2026-02-26 | -7.71 |
| 2026-02-25 | -7.39 |
| 2026-02-24 | -7.49 |
| 2026-02-23 | -6.55 |
| 2026-02-20 | -6.05 |
| 2026-02-19 | -5.72 |
| 2026-02-18 | -5.62 |
| 2026-02-17 | -5.71 |
| 2026-02-13 | -5.81 |
| 2026-02-12 | -5.80 |
| 2026-02-11 | -5.90 |
| 2026-02-10 | -6.05 |
| 2026-02-09 | -6.21 |
| 2026-02-06 | -6.23 |
| 2026-02-05 | -6.39 |
| 2026-02-04 | -6.44 |
| 2026-02-03 | -6.61 |
| 2026-02-02 | -6.24 |
| 2026-01-30 | -5.95 |
| 2026-01-29 | -6.25 |
| 2026-01-28 | -6.57 |
| 2026-01-27 | -6.65 |
| 2026-01-26 | -6.72 |
| 2026-01-23 | -6.87 |
| 2026-01-22 | -6.77 |
| 2026-01-21 | -6.77 |
| 2026-01-20 | -7.06 |
| 2026-01-16 | -7.20 |
| 2026-01-15 | -6.67 |
| 2026-01-14 | -5.63 |
| 2026-01-13 | -5.44 |
| 2026-01-12 | -8.21 |
| 2026-01-09 | -6.98 |
| 2026-01-08 | -4.92 |
| 2026-01-07 | -4.29 |
| 2026-01-06 | -4.00 |
| 2026-01-05 | -3.91 |